---
figid: PMC9283766__fnagi-14-890509-g002
figtitle: 'Insights Into the Role of Platelet-Derived Growth Factors: Implications
  for Parkinson’s Disease Pathogenesis and Treatment'
organisms:
- NA
pmcid: PMC9283766
filename: fnagi-14-890509-g002.jpg
figlink: /pmc/articles/PMC9283766/figure/F2/
number: F2
caption: Platelet-derived growth factor (PDGF)-mediated pathological signaling mechanisms
  in Parkinson’s disease (www.figdraw.com). The binding of PDGF ligands and receptors
  can activate the PI3K/AKT/GSK-3β and MEK/ERK pathways to activate the transcription
  factor cycle response element binding protein (CREB) to promote the generation of
  tyrosine hydroxylase (TH). PDGFs can activate the P38 and JNK MAPK/GSK-3β/β-catenin
  signaling cascade. They can also activate the PLC/PI3R pathway to further activate
  the transient receptor potential canonical (TRPC) channel. As a result, Ca2+ elevation
  is triggered to suppress the GSK3β signal, which further leads to the accumulation
  of β-serial protein and gene expression related to cell survival. At the same time,
  elevated Ca2+ can activate the PYK2/ERK pathway, resulting in CREB activation.
papertitle: 'Insights Into the Role of Platelet-Derived Growth Factors: Implications
  for Parkinson’s Disease Pathogenesis and Treatment.'
reftext: Dan Li, et al. Front Aging Neurosci. 2022;14:890509.
year: '2022'
doi: 10.3389/fnagi.2022.890509
journal_title: Frontiers in Aging Neuroscience
journal_nlm_ta: Front Aging Neurosci
publisher_name: Frontiers Media S.A.
keywords: platelet-derived growth factor | Parkinson’s disease | dopaminergic neurons
  | oxidative stress | calcium homeostasis
automl_pathway: 0.956032
figid_alias: PMC9283766__F2
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC9283766__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9283766__fnagi-14-890509-g002.html
  '@type': Dataset
  description: Platelet-derived growth factor (PDGF)-mediated pathological signaling
    mechanisms in Parkinson’s disease (www.figdraw.com). The binding of PDGF ligands
    and receptors can activate the PI3K/AKT/GSK-3β and MEK/ERK pathways to activate
    the transcription factor cycle response element binding protein (CREB) to promote
    the generation of tyrosine hydroxylase (TH). PDGFs can activate the P38 and JNK
    MAPK/GSK-3β/β-catenin signaling cascade. They can also activate the PLC/PI3R pathway
    to further activate the transient receptor potential canonical (TRPC) channel.
    As a result, Ca2+ elevation is triggered to suppress the GSK3β signal, which further
    leads to the accumulation of β-serial protein and gene expression related to cell
    survival. At the same time, elevated Ca2+ can activate the PYK2/ERK pathway, resulting
    in CREB activation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ca
  - Akt
  - arm
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Jra
  - CrebB
  - CrebA
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - norpA
  - sl
  - Plc21C
  - Dsor1
  - Mtk
  - Erk7
  - rl
  - Itpr
  - AKT1
  - AKT2
  - AKT3
  - CTNNB1
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDGFRB
  - PDGFRA
  - JUN
  - JUNB
  - JUND
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - TH
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - ITPR1
  - ITPR3
  - PTK2B
---
